P.E.Analytics IPO Details: Price, Dates & Financials
The P.E.Analytics IPO GMP strength score is 7.7 out of 10, which the dashboard rates as Good. The P.E.Analytics IPO valuation is tagged Strong. The P.E.Analytics IPO QIB category is reserved for 47.45% of the offer. The P.E.Analytics IPO NII/HNI category is reserved for 14.29% of the offer. The P.E.Analytics IPO Retail (RII) category is reserved for 33.25% of the offer. Live subscription numbers for the P.E.Analytics IPO are not yet available, and amounts are calculated at the upper price band of ₹114.
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| QIB | — | 1,315,200 (47%) | — |
| NII / HNI | — | 396,000 (14%) | — |
| Retail (RII) | — | 921,600 (33%) | — |
| Market Maker | — | 139,200 (5%) | — |
| Total | — | 2,772,000 (100%) | — |
* Amount calculated at upper price band (₹114) · ** Total includes all investor categories
- 1 Initiation of Refund 31 Mar 2022
- 2 Credit of Shares to Demat 01 Apr 2022
- Retail allocation is good at 33% of the total offering.
- HNI/NII demand is good at 14%.
- Institutional (QIB) interest is strong at 47%.
- The IPO P/E of 15x reflects a strong valuation relative to typical market ranges.
This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.